Treatment of chronic hepatitis C with weekly administration of interferon-α
✍ Scribed by Morizane, Toshio ;Kagawa, Tatehiro ;Saito, Hidetsugu ;Guevara, Ferdinand M. ;Miyaguchi, Shingo ;Tsuchiya, Masaharu
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 154 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Twelve children with chronic non-A, non-B hepatitis were entered in a pilot trial of recombinant interferon-alpha. Although all the children had hepatitis C virus RNA in serum, only five had antibodies against this virus. Children received 3 MU/m2 body surface area interferon-alpha 3 times/wk for 6
Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res
## Abstract A pilot study of chronic hepatitis C treatment was conducted in 14 patients (13 had chronic active hepatitis and 1 had liver cirrhosis). All patients were asymptomatic for the human immunodeficiency virus (HIV) type 1 (mean CD4 count of 584 ± 283 cells/mm^3^). Patients received 9 MU rlF
Hepatitis C virus RNA as detected by reverse transcription and nested polymerase chain reaction was monitored in 16 patients with chronic hepatitis C treated with interferon. Hepatitis C virus R N A became undetectable after 4 to 8 wk of interferon administration in 13 of the 16 patients. During 6 m